At CPHI Frankfurt 2025, the world’s leading event for the pharmaceutical industry, the winners of the Pharma Awards (to be presented during the fair) were announced, celebrating outstanding achievements in biopharmaceutical development, packaging, and drug delivery solutions.This year’s edition will feature three companies whose projects embody the most relevant trends in the sector: PharmEVO, Maggie Mix (by SHL Medical), and Ypsomed.
PharmEVO: access and sustainability
PharmEVO impressed the jury with a model that combines scientific research, social responsibility, and sustainability. Active in emerging markets, the company presented a project aimed at broadening access to advanced therapies through scalable solutions and eco-friendly packaging designed to minimize environmental impact. This is not only about technological innovation but also about a systemic approach that integrates patient inclusion with a responsible product life cycle.
Maggie Mix: smart formulations
Developed by SHL Medical, Maggie Mix focused on the core of pharmaceutical development: formulation. Its breakthrough technology introduces new standards in drug stability and dosing precision, with a strong emphasis on treatment personalization. This result has been made possible by integrating artificial intelligence into manufacturing processes. Predictive algorithms help optimize drug composition while reducing development time and costs. The connection with packaging is crucial, as smart formulations require containment and delivery systems that guarantee both integrity and usability.
Ypsomed: the self-injection revolution
The most anticipated award went to Ypsomed, a pioneer in capturing the global trend of self-injections, fueled by the success of therapies such as the antidiabetic drug Ozempic. The Swiss company stood out with its next-generation auto-injectors, designed to improve adherence and simplify the daily lives of chronic patients. Ergonomic design, safety features, and user-friendly interfaces make these devices accessible even for individuals without medical experience, reducing dependency on healthcare facilities and paving the way for more decentralized care models.
Is Ozempic a growing packaging trend?
The spotlight on self-injections is no coincidence: the global market for at-home injectable therapies is expanding rapidly and is set to reshape production and distribution dynamics. These are not just medical devices, but part of an ecosystem that involves primary packaging, supply chain, regulatory compliance, and user experience. The challenge is twofold: ensuring maximum safety in the preservation of active ingredients while delivering intuitive tools that increase patient autonomy.
Beyond the awards: a signal for the future
The 2025 Pharma Awards tell the story of a supply chain evolving at high speed: from AI-driven formulations to sustainable packaging, and self-injection devices that echo the consumer-tech model. Together, they anticipate the future of healthcare: personalized, digital, and patient-centered.
Once again, CPHI Frankfurt 2025 confirms its role as a key observatory for industry trends, offering concrete insights for manufacturers, packaging suppliers, and pharmaceutical companies as they rethink business models and innovation strategies.
